ZEN-003694 (ZEN-3694)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZEN-003694 (ZEN-3694), covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial [Phase 2]